Journal of International Oncology››2015,Vol. 42››Issue (2): 84-87.doi:10.3760/cma.j.issn.1673-422X.2015.02.002
Previous ArticlesNext Articles
Qin Xiaoling, Yang Fan, Yu Zhilong
Online:
2015-02-08Published:
2015-02-02Contact:
Qin Xiaoling E-mail:1018886023@qq.comQin Xiaoling, Yang Fan, Yu Zhilong. Radiotherapy curative effects for single or multiple brain metastases[J]. Journal of International Oncology, 2015, 42(2): 84-87.
[1] 刘原照, 李高峰, 刘明远, 等. 老年人脑转移瘤X线立体定向放射治疗疗效分析[J]. 中华老年医学杂志, 2005, 24(1): 24-25. [2] Lin NU. Targeted therapies in brain metastases[J]. Curr Treat Options Neurol, 2014, 16(1): 276. [3] Hendriks LE, Troost EG, Steward A, et al. Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: impact of a new Dutch guideline on brain metastases[J]. Acta Oncol, 2014, 53(7): 945-951. [4] Nieder C, Grosu AL, Gaspar LE, et al. Stereotactic radiosurgery (SRS) for brain metastases: a systematic review[J]. Radiat Oncol, 2014, 9: 155. [5] Duan L, Zeng R, Yang KH, et al. Whole brain radiotherapy combined with stereotactic radiotherapy versus stereotactic radiotherapy alone for brain metastases: a metaanalysis[J]. Asian Pac J Cancer Prev, 2014, 15(2): 911915. [6] Patil CG, Pricola K, Garg SK, et al. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases[J]. Cochrane Database Syst Rev, 2010(6): CD006121. [7] Li B, Yu J, Suntharalingam M, et al. Comparison of three treatment options for single brain metastasis from lung cancer[J]. Int J Cancer, 2000, 90(1): 37-45. [8] Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with wholebrain radiotherapy for brain metastases[J]. J Clin Oncol, 1998, 16(11): 3563-3569. [9] Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase Ⅲ results of the RTOG 9508 randomised trial[J]. Lancet, 2004, 363(9422): 1665-1672. [10] Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus wholebrain irradiation: a randomised controlled trial[J]. Lancet Oncol, 2009, 10(11): 1037-1044. [11] Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus wholebrain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial[J]. JAMA, 2006, 295(21): 2483-2491. [12] Chao ST, Barnett GH, Vogelbaum MA, et al. Salvage stereotactic radiosurgery effectively treats recurrences from wholebrain radiation therapy[J]. Cancer, 2008, 113(8): 2198-2204. [13] Rades D, Pluemer A, Veninga T, et al. Wholebrain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases[J]. Cancer, 2007, 110(10): 2285-2292. [14] Caballero JA, Sneed PK, Lamborn KR, et al. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2012, 83(1): 303-309. [15] LuEmerson C, Eichler AF. Brain metastases[J]. Continuum (Minneap Minn), 2012, 18(2): 295-311. |
[1] | Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[4] | Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156. |
[5] | Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174. |
[6] | Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42. |
[7] | Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552. |
[8] | Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367. |
[9] | Lyu Lu, Sun Pengfei.Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376. |
[10] | Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association.Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy (2023 version)[J]. Journal of International Oncology, 2023, 50(4): 193-201. |
[11] | Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng.Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance[J]. Journal of International Oncology, 2023, 50(4): 227-230. |
[12] | Shi Xaioqi, Wang Hongyan.Research progress on the interaction between gut microbiota and radiation enteritis[J]. Journal of International Oncology, 2023, 50(4): 244-247. |
[13] | Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun.Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases[J]. Journal of International Oncology, 2023, 50(3): 138-143. |
[14] | Huang Huayu, Gong Hongyun, Song Qibin.Influencing factors of pneumonitis in the period of thoracic radiotherapy combined with immunotherapy[J]. Journal of International Oncology, 2023, 50(2): 102-106. |
[15] | Cao Xiaohui, Yu Hong, Li Wanhu.Application of CT-based radiomics analysis in predicting and identifying of treatment-associated pneumonitis[J]. Journal of International Oncology, 2023, 50(2): 107-111. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||